The latest tool for CRISPR gene editing is a new CRISPR-C2C2 (Cas13a) system which utilizes RNA-guided RNA-targeting for RNA knockdown and binding in cells. C2C2 (Cas13a) may be useful for isolating specific RNA sequences or even studying single RNA molecules with high specificity. Unlike editing DNA as with Cas9 which makes permanent genomic changes, targeting RNA with C2C2 allows temporarily altering the amount of protein potentially offering a better therapeutic approach in the future.
Use Diagenode's new C2C2 (Cas13a) polyclonal antibody to determine precision and success metrics in CRISPR experiments.
| Cat. No. | Product | 実験手法 | 純度 | |
|---|---|---|---|---|
| C15310267-100 |
C2C2 Antibody (100 μl) |
WB | Whole antiserum from rabbit containing 0.05% azide. | |
| C15200249 |
C2C2 Antibody (50 µg/50 µl) |
WB | Protein G purified monoclonal antibody | |
| C15100149 |
LwaCas13a Antibody (100 µl) |
WB | Concentrated cell culture supernatant. | |
| C15200250 |
PspCas13b Antibody (50 µg) |
WB | Protein G purified monoclonal antibody. |
The European Regional Development Fund and Wallonia are investing in your
future.
Extension of industrial buildings and new laboratories.
